Fluconazole Related Published Studies
Well-designed clinical trials related to Fluconazole
A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. [2009.06.15]
The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. [2009.04]
Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. [2009.03]
Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. [2009.02.02]
Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. [2009.01.05]
A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor. [2009.01]
Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial. [2008.11.15]
Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. [2008.07.15]
Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU? [2008.06]
Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. [2008.05]
Effect of multiple oral dosing of fluconazole on the pharmacokinetics of cyclosporine in healthy beagles. [2008.01]
Effects of nystatin, fluconazole and propolis on poly(methyl methacrylate) resin surface. [2008]
Fluconazole Prophylaxis against Fungal Colonization and Invasive Fungal Infection in Very Low Birth Weight Infants. [2007.11.07]
[The impact of itraconazol versuse fluconazole on the prevention of postoperative invasive fungal infections after orthotopic liver transplantation] [2007.11]
Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants. [2007.11]
Bioavailability of oral fluconazole in critically ill abdominal trauma patients with and without abdominal wall closure: a randomized crossover clinical trial. [2007.07]
A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. [2007.06.14]
Anidulafungin versus fluconazole for invasive candidiasis. [2007.06.14]
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. [2007.01.25]
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. [2007.01.25]
Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene. [2007.01]
Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients. [2006.08]
Terbinafine versus itraconazole and fluconazole in the treatment of Vulvovaginal candidiasis. [2006.07]
A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients. [2006.07]
Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-Ibuprofen. [2006.06]
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. [2006.04.15]
Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg. [2006.04]
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. [2006.02]
Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. [2006.01]
Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. [2006.01]
An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis. [2005.12]
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40. [2005.11.15]
A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. [2005.11]
Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide. [2005.11]
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. [2005.10.22]
A randomized, open-label pharmacokinetic comparison of two oral formulations of fluconazole 150 mg in healthy adult volunteers. [2005.10]
Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis. [2005.09]
Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. [2005.08]
Bioequivalence evaluation of two formulations of fluconazole 150 mg capsule in healthy Arab men. [2005.05]
A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis. [2005.04.01]
Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant. [2005.04]
Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole. [2005.02]
Evaluation of the bioequivalence of capsules containing 150 mg of fluconazole. [2005.01.06]
Well-designed clinical trials possibly related to Fluconazole
Efungumab: A Novel Agent in the Treatment of Invasive Candidiasis (November). [2009.09.22]
Double-blind active-control trials: beware the comparator you keep. [2008.10.15]
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. [2008.07.01]
Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. [2008.05.20]
Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. [2008.05.15]
Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia. [2008.03]
Anidulafungin in the treatment of invasive fungal infections. [2008.02]
Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis. [2007.10]
Posaconazole: an extended-spectrum triazole antifungal agent. [2007.09]
Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients. [2007.08]
AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans. [2007.06]
Tacrolimus powder in Orabase 0.1% for the treatment of oral lichen planus and oral lichenoid lesions: an open clinical trial. [2006.12]
The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa. [2006.09]
The debate: The trials have told us very little. [2006.09]
Delayed ABLC prophylaxis after allogeneic stem-cell transplantation. [2006.09]
A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II. [2006.06]
Reducing warfarin medication interactions: an interrupted time series evaluation. [2006.05.08]
Evidence for a basal release of a cytochrome-related endothelium-derived hyperpolarizing factor in the radial artery in humans. [2006.04]
Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity. [2005.10]
Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV. [2005.07.20]
The role of CYP2C and CYP3A in the disposition of 3-keto-desogestrel after administration of desogestrel. [2005.07]
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. [2005.06.15]
Initial treatment of cryptococcal meningitis in AIDS. [2005.01]
Other research related to Fluconazole
The Effect Of Fluconazole Prophylaxis In Very Low Birthweight Infants Is Over-Estimated By Before-After Studies. [2009.10.11]
Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT. [2009.10.05]
The use of fluconazole in neonatal intensive care units. [2009.08.31]
Liposomes as an ocular delivery system of fluconazole: in-vitro studies. [2009.08.14]
Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia. [2008.12.01]
Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation. [2008.12]
Severe cutaneous adverse drug reaction due to fluconazole. [2008.11]
Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients. [2008.10]
Association of fluconazole pharmacodynamics with mortality in patients with candidemia. [2008.09]
[Effect of qishen huoxue granule combined with fluconazole on survival rate of mice with systemic C. albaicans infection] [2008.09]
Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies. [2008.08]
Life-threatening serotonin toxicity due to a citalopram-fluconazole drug interaction: case reports and discussion. [2008.07]
Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. [2008.07]
Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis. [2008.06]
Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole. [2008.06]
Torsades de pointes in a patient receiving fluconazole for cerebral cryptococcosis. [2008.04.01]
Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. [2008.04]
Rhabdomyolysis induced by simvastatin-fluconazole combination. [2008.04]
Efficacy of fluconazole subconjunctival injection as adjunctive therapy for severe recalcitrant fungal corneal ulcer. [2008.03]
Release profiles and morphological characterization by atomic force microscopy and photon correlation spectroscopy of 99mTechnetium-fluconazole nanocapsules. [2008.02.12]
Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials. [2008.02]
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl. [2008.01]
Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: A metaanalysis of randomized controlled trials. [2007.12.07]
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl. [2007.11.07]
Voriconazole and fluconazole increase the exposure to oral diazepam. [2007.10]
Catheter-related fungemia due to fluconazole-resistant Candida nivariensis. [2007.10]
Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia. [2007.10]
Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. [2007.07.01]
Fluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation. [2007.07]
Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor. [2007.07]
Association between fluconazole susceptibility and genetic relatedness among Candida tropicalis isolates in Taiwan. [2007.05]
High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis. [2007.05]
Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model. [2007.05]
Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits. [2007.04]
Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole. [2007.03.12]
|
